Clinical Trials on Secondary Hypogonadism

Total 1732 results

Clarus Therapeutics, Inc.

Completed

Pharmacokinetic Study to Determine Time to Steady-state

Male Hypogonadism | Secondary Hypogonadism | Primary Hypogonadism

United States
Endo Pharmaceuticals

Completed

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men (TU)

Hypogonadism | Secondary Hypogonadism | Primary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism
Repros Therapeutics Inc.

Completed

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism (ZA-003Ext)

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.
Celerion

Completed

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Gulhane School of Medicine

Completed

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

Secondary Hypogonadism

Turkey
Repros Therapeutics Inc.

Completed

Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function

Secondary Hypogonadism

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function

Secondary Hypogonadism

United States
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...

Unknown

Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men

Sexual Dysfunction | Erectile Dysfunction | Secondary Hypogonadism

United States
Rigshospitalet, Denmark

Terminated

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Hypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, Male

Denmark
Shanghai Jiao Tong University School of Medicine

Unknown

Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism
Endo Pharmaceuticals

Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Hypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, Male

United States
Amneal Pharmaceuticals, LLC
Phase One Solutions, Inc.

Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Hypogonadotropic Hypogonadism | Primary Hypogonadism

United States
National Institute of Environmental Health Sciences...

Recruiting

Observation of Environment and Reproductive-Endocrine Effects

Precocious Puberty | Hypogonadism | Amenorrhea | Hypergonadism | Late Puberty

United States
Repros Therapeutics Inc.

Completed

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Obesity | Acquired Hypogonadotropic Hypogonadism

United States
Massachusetts General Hospital

Recruiting

Neuropeptides in Human Reproduction

Hypogonadotropic Hypogonadism

United States
Mereo BioPharma

Completed

A 6 Month Safety Extension Study of MBGS205

Hypogonadotropic Hypogonadism

United States
Organon and Co

Completed

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

Hypogonadotropic Hypogonadism | Hypogonadism
Texas Tech University Health Sciences Center

Completed

Effect of Intranasal Insulin on LH Concentrations in Man

Hypogonadotropic Hypogonadism

United States
Clarus Therapeutics, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaN...

Completed

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Male Hypogonadism

United States, Germany
Clarus Therapeutics, Inc.
inVentiv Health Clinical

Completed

Safety and Efficacy Trial of Testosterone Undecanoate

Male Hypogonadism

United States
Lipocine Inc.
PPD; Syneos Health

Completed

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism (SOAR)

Male Hypogonadism
Fudan University

Recruiting

An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients (LPS-IHH)

Idiopathic Hypogonadotropic Hypogonadism | Luteal Phase Support | Luteal Phase Deficiency

China
Huashan Hospital

Recruiting

Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH

Hypogonadotropic Hypogonadism

China
Stephanie B. Seminara, MD

Recruiting

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United States
Stephanie B. Seminara, MD

Enrolling by invitation

Opioid Antagonism in Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United States
Azienda Ospedaliero-Universitaria di Modena

Recruiting

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men (RHYTHM)

Acquired Hypogonadotropic Hypogonadism

Italy
Marius Pharmaceuticals
Syneos Health

Completed

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Lipocine Inc.

Completed

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). (DV)

Hypogonadism, Male
Lund University

Completed

Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males

Hypogonadism, Male
Ferring Pharmaceuticals

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Adult Male Hypogonadism

United States
GlaxoSmithKline

Completed

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

Hypogonadism | Hypogonadism, Male

United States
Gulhane School of Medicine

Completed

The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
Gulhane School of Medicine

Completed

Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
Gulhane School of Medicine

Completed

Effects of Medications in Patients With Hypogonadism

Idiopathic Hypogonadotropic Hypogonadism

Turkey
University of Washington
Washington State University

Not yet recruiting

Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 (OralT12)

Hypogonadism, Male
University of Florida
Acerus Pharmaceutical

Recruiting

Natesto Spermatogenesis Reboot

Hypogonadism, Male

United States
The Royal Wolverhampton Hospitals NHS Trust

Active, not recruiting

Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses (Sal T)

Hypogonadism, Male

United Kingdom

3

Subscribe